September 30, 2015
The First Circuit told a Massachusetts federal court to rethink blocking a whistleblower from amending his suit alleging a Covidien Ltd. unit got Medicare to illegally fund off-label uses for its blood-blockage device on Wednesday.
October 01, 2014
A Massachusetts federal judge on Tuesday tossed a whistleblower’s False Claims Act suit accusing a Covidien Ltd. subsidiary of, among other things, promoting off-label uses for its blood-blockage device, saying the suit was precluded by the public disclosure bar and a lack of evidence.